News & Deep Analysis
PM

Philip Morris (PM) Reports 2025 Revenue Growth

Published: February 18, 2026
Philip Morris International Inc.

Direct News

  • Net revenues up 7.3% in 2025 to $40,648 million.
  • Operating income rose 11.8% to $14,892 million in 2025.
  • Gross profit: $27,282 million; net earnings: $11,848 million.
  • SFPs (smoke-free products) made up 22.8% of 2025 shipment volume (179.1bn of 786.5bn equivalent units).
  • Product shipment mix: Cigarettes 607.4bn (77.2%, -1.5% YoY); HTU 155.1bn (+11.0% YoY); Oral SFP 20.7bn (+18.5% YoY); E-vapor 3.3bn (+100% YoY).
  • Balance sheet highlights: Total assets ~ $100,000M (inferred); long-term debt $45,134M; stockholders' deficit $(8,028)M.

Historical Context

The 2025 results form part of Philip Morris’s multi-year push toward a smoke-free future. SFP volume growth in 2025 (+12.8% year-over-year for total SFPs) follows prior investment in IQOS and the acquisition of U.S. oral nicotine assets that underpin ZYN expansion. On 2026-02-18 management reaffirmed 2026 EPS guidance and signaled an upward revision in expected adjusted EPS growth for 2026, reflecting confidence in margin improvement and SFP scale-up. Prior impairments and provisions — for example, a 2024 impairment tied to a stake in RBH related to a proposed Canadian settlement — remain part of the company’s recent financial backdrop.

Financial highlights and investor implications

Philip Morris reported a 7.3% increase in net revenues for 2025, reaching $40,648 million, with operating income up 11.8% to $14,892 million and gross profit of $27,282 million. Net earnings totaled $11,848 million. Reported diluted EPS is listed as N/A, with management pointing to adjusted measures as the primary growth drivers. For investors, the combination of revenue growth outpacing cigarette volume declines and higher operating income indicates improving margin leverage. However, the company carries significant leverage (long-term debt $45,134M) and a reported stockholders' deficit of $(8,028)M, which remain material balance-sheet considerations when evaluating capital allocation and risk.

Smoke-free products (SFPs) driving top-line composition change

SFPs reached 22.8% of total shipment volume in 2025 (179.1 billion equivalent units of 786.5 billion), underscoring management's strategic pivot toward smoke-free alternatives. Heat-not-burn (HTU) volumes grew 11.0% year-over-year to 155.1 billion units, oral SFPs rose 18.5% to 20.7 billion units, and e-vapor doubled to 3.3 billion units (100% YoY). Cigarette shipments remain the largest component at 607.4 billion units (77.2% of volume), down 1.5% year-over-year. The data show a clear execution-led transition: SFP growth is meaningful but cigarettes still drive the majority of unit volume and, historically, cash flow.

Strategy execution and structural outlook

Management continues to pursue a comprehensive smoke-free transformation and announced a two-unit reporting structure effective January 1, 2026 (International/U.S.) to improve agility. The company emphasizes scale-ups in IQOS (HTU) and ZYN (oral nicotine pouches) as primary growth engines and is investing in wellness via Aspeya. R&D and product investment remain concentrated on smoke-free platforms — the company reports $16 billion invested in smoke-free technology since 2008 and positions IQOS, ZYN and wellness offerings as core to its medium-term growth plan. Execution will determine whether SFPs can narrow dependence on combustible product economics.

Risks and regulatory/legal considerations

Philip Morris faces several material legal and regulatory risks that could affect earnings or cash flow. Notable items include ongoing U.S. litigation related to nicotine addiction claims against ZYN (multiple cases in 2024–2025 with no accruals), a proposed CAD 32.5 billion Canadian tobacco settlement tied to an impaired 2024 charge on a 23% stake in RBH, and excise/tax assessments such as Germany’s EUR 151 million TEREA classification. Italy anti-corruption probes and tariffs/ taxes in markets like Egypt and Russia add further geopolitical and regulatory complexity. Macro sensitivities include currency volatility (examples cited in 2025) and exposure to higher global interest rates on a $45 billion debt load. Investors should weigh SFP growth against this legal and macro backdrop when assessing risk-adjusted returns.

Competitive positioning and moat assessment

Primary competitors include British American Tobacco, Japan Tobacco and Imperial Brands. The company’s advantages are execution- and brand-driven rather than exhibiting a sustainable structural economic moat. Marlboro remains a valuable pricing asset (10.7% cigarette share internationally; 43% of cigarette volume in Europe by brand in relevant markets), and IQOS technology provides a portable IP edge — however, patent disputes (e.g., FTKK Japan suits on TEREA/SENTIA) and rival product rollouts signal that these protections are not unassailable. Cost advantages such as direct farmer sourcing (23% of 2025 leaf) and procurement scale are meaningful but replicable. In short, PMI’s lead is operational: sustained outperformance will depend on continued execution, product uptake in SFPs, and successful navigation of regulatory and legal headwinds.

Investor FAQ

The most effective approach is to maintain a factual perspective. Keep a close watch on further developments at Philip Morris International Inc. as they unfold. Use primary source data to validate your investment thesis rather than relying on delayed secondary reports.

You can set up an automated tracker on Portrak. Our system monitors official SEC filings in real-time, delivering the most critical insights to your phone or inbox seconds after publication—frequently before the information reaches major financial news platforms.

We believe quality intelligence should be accessible. Our business model is supported by professional investors with large, complex portfolios who utilize Portrak Pro. These users pay to automate the monitoring of extensive watchlists, saving hundreds of hours in research time, which allows us to keep the standard service free for individual investors tracking their core positions.

Setting up your automated intelligence pipeline is a simple 3-step process:

1

Create Your Free Account

Sign up or log in to access your personal dashboard.

2

Select Your Focus

Use the search bar to find companies like Philip Morris International Inc.. Choose between monitoring specific events or receiving general market-moving intelligence. Our AI automatically determines what’s critical based on real-time market data and the company’s current profile.

3

Receive Real-Time Intelligence

Once activated, all official filings are analyzed instantly. Insights are delivered directly to your email or as a push notification if you use the Portrak mobile app.

Also available as a mobile app for iOS & Android—search for "Portrak"

More Strategic Insights

PM
May 20, 2026

Philip Morris Names Group CFO — Massimo Andolina

Read Analysis
PM
Mar 5, 2026

Philip Morris Declares $1.47 Quarterly Dividend

Read Analysis
PM
Feb 18, 2026

Philip Morris Shifts Focus to Smoke-Free (PM)

Read Analysis
PM
Feb 18, 2026

PM: PMI Details Smoke-Free Strategy Update

Read Analysis